Related Experiment Video
Updated: Jun 10, 2025
12:03
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
26.1K
Synergistic oral beta-lactam combinations for treating tuberculosis
Diana H Quan1, Trixie Wang1, Elena Martinez2
1Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006 NSW, Australia.
Journal of Applied Microbiology
|October 12, 2024
Summary
Beta-lactam antibiotics show promise for treating tuberculosis (TB). Combining specific beta-lactams with clavulanate demonstrated synergy, suggesting new therapeutic options for this global health challenge.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Tuberculosis (TB) poses a significant global health burden, with limited treatment options due to drug discovery challenges.
- Repurposing existing antimicrobial drugs is a viable strategy to expand TB treatment possibilities.
- Beta-lactams and beta-lactamase inhibitors are underutilized in TB treatment.
Purpose of the Study:
- To investigate the in vitro activity and synergy of beta-lactams in combination with beta-lactamase inhibitors against Mycobacterium tuberculosis.
- To evaluate the potential of these combinations as novel therapeutic strategies for TB.
Main Methods:
- Seven beta-lactams, two beta-lactamase inhibitors (avibactam, clavulanate), and three second-line TB drugs were selected based on specific criteria.
- In vitro testing against Mycobacterium tuberculosis H37Rv using resazurin assays and colony forming unit enumeration.
- Chou-Talalay and Chou-Martin calculations were used to assess drug synergy and dose reduction.
Main Results:
- Beta-lactam activity varied, with cefadroxil being the most potent.
- Clavulanate enhanced beta-lactam activity more effectively than avibactam.
- Synergistic effects were observed for several beta-lactam/clavulanate combinations, while combinations with second-line TB drugs showed antagonism, with notable exceptions.
Conclusions:
- Beta-lactam and clavulanate combinations demonstrate synergistic activity against Mycobacterium tuberculosis.
- These findings suggest that beta-lactam synergy could offer viable combination therapies for TB treatment.
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:28Pneumonia IV: Management
304
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
304
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:28Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212